ArticleBioengineering (Basel, Switzerland)2026
Explainable Quality Assessment and Measurement from Real-World Hip Ultrasound Cine Sweeps.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluates Retuve, an open-source explainable pipeline for the automated analysis of infant hip ultrasound cine sweeps. Retuve combines segmentation, Graf-plane calibration, and frame filtering. In a retrospective multicenter study, we tested the full pipeline on an external set of 109 hips from a Canadian community clinic, with internal developmental validation of segmentation on 90 hips and Graf-plane calibration on 419 hips. On the external test set, Retuve achieved 100% specificity and 91% sensitivity for expert agreement regarding whether a sweep contained an analyzable frame, compared with 75% specificity and 96% sensitivity for a radiology fellow; specificity was based on 16 expert-negative examinations. For alpha angle and acetabular coverage, Retuve achieved consistency intraclass correlation coefficients (ICCs) of 0.77 and 0.74, comparable to the fellow's 0.70 and 0.74. However, alpha-angle absolute agreement was lower (ICC 0.55, 95% confidence interval (CI) -0.07-0.81), consistent with systematic measurement bias. Internal developmental validation showed Component 1 mask mean average precision at 50% intersection-over-union (mAP50) of 0.753 and box mAP50 of 0.883 and a Component 2 ICC of 0.792. Retuve can select analyzable frames and recover measurements from variable-quality cine sweeps, but alpha-angle calibration requires refinement. Future prospective work should evaluate developmental dysplasia of the hip (DDH) diagnostic accuracy, clinical treatment decision support, and screening outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.